BENGALURU (Reuters) - Reliance Industries Ltd, India's most valuable company, on Friday reported a 19.10% rise in fourth-quarter profit, helped by the performance of its mainstay energy unit.
Consolidated profit at the Mukesh Ambani-led conglomerate rose to 192.99 billion rupees ($2.35 billion) in the quarter ended March 31, from 162.03 billion rupees a year earlier, it said in an exchange filing.
($1 = 82.0850 Indian rupees)
(Reporting by Nallur Sethuraman in Bengaluru; Editing by Dhanya Ann Thoppil)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,905 INR | -0.51% | -1.20% | 221B | ||
| 2,686 PTS | +0.86% | +0.34% | - | ||
Mukesh Dhirubhai Ambani is a businessperson who has been at the head of 6 different companies and occupies the position of Chairman & Managing Director at Reliance Industries Ltd., Chairman of Reliance Life Sciences Pvt Ltd. and Principal at Reliance Jio Infocomm Ltd. (Venture Capital). Mr. Ambani is also Chairman-Governors Board at Pandit Deendayal Petroleum University, Member-Millennium Development Goals at United Nations (New York), Member of National Academy of Engineering, Member of The Business Council, Member of Asia Business Council, Member of Prime Ministers Council on Trade & Industry and Member of US India CEO Forum and on the board of 12 other companies. In his past career he held the position of Member-Global Advisory Council at Bank of America Corp., Chairman at Indian Petrochemicals Corp. Ltd., Owner at Reliance Gas Transportation Infrastructure Ltd., Director-Governors Board at Indian Institute of Management Bangalore and Member-Governing Board at Public Health Foundation. He received an MBA from Stanford University and an undergraduate degree from Institute of Chemical Technology.
View full profile| Linked companies | |
|---|---|
| RELIANCE INDUSTRIES LTD | Chief Executive Officer |
Reliance Life Sciences Pvt Ltd.
 Reliance Life Sciences Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Reliance Life Sciences Pvt Ltd. provides biotechnology clinical research services. Its services include pre clinical services, phase-I, biometrics, cardiac safety studies, medical writing, and pharmacovigilance. The company was founded by Dhirubhai H. Ambani in 2001 and is headquartered in Mumbai, India. | Chairman |
